Dinoprostone

prostaglandin E receptor 3 ; Homo sapiens







151 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 23087260 Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor. 2013 Jan 1
52 23246486 Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1. 2013 Mar 1
53 23338277 Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression. 2013 Mar 1
54 23349487 Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. 2013 Jun 2
55 23766266 Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. 2013 Aug 1
56 23892039 Molecular and pharmacological characterization of zebrafish 'contractile' and 'inhibitory' prostanoid receptors. 2013 Aug 23 1
57 23904482 Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. 2013 Aug 13 3
58 24046862 Cellular senescence involves an intracrine prostaglandin E2 pathway in human fibroblasts. 2013 Jul 1
59 24062570 EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins. 2013 Dec 1
60 22475642 Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells. 2012 Nov 3
61 21059804 Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors. 2011 Feb 1
62 21070749 Prostaglandin E₂ regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells. 2011 Feb 1 1
63 21095237 PGE1 and PGE2 modify platelet function through different prostanoid receptors. 2011 Feb 1
64 21932512 [Prostaglandin(PG) E2 in regulation of immunity and inflammatory diseases]. 2011 Jun 1
65 19843025 Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. 2010 Feb 1 1
66 20094648 Limitations of current therapies to prevent thrombosis: a need for novel strategies. 2010 Feb 2
67 20219142 Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear. 2010 Mar 11 2
68 20451959 PGE2 decreases reactivity of human platelets by activating EP2 and EP4. 2010 Jul 2
69 20951077 A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. 2010 Dec 3
70 21041985 Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. 2010 3
71 18843255 Hypertonicity stimulates PGE2 signaling in the renal medulla by promoting EP3 and EP4 receptor expression. 2009 Feb 2
72 19210337 Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells. 2009 Jun 1
73 19212690 Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240. 2009 Mar 4
74 19729667 Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. 2009 Nov 15 1
75 17906615 Prostanoid receptor EP1 expression in breast cancer. 2008 Jan 1
76 18042549 Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. 2008 Jan 25 2
77 18097066 Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. 2008 Jan 1 2
78 18480467 Bradykinin-stimulated cyclooxygenase activity stimulates vas deferens epithelial anion secretion in vitro in swine and humans. 2008 Sep 1
79 18508878 Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice. 2008 Aug 1
80 18652829 Involvement of non-conserved residues important for PGE2 binding to the constrained EP3 eLP2 using NMR and site-directed mutagenesis. 2008 Aug 20 1
81 19012178 DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. 2008 Dec 1
82 19227010 Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. 2008 1
83 17692121 Prostaglandin E2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neurons. 2007 Aug 10 2
84 16300797 Characteristics of acid extrusion from Chinese hamster ovary cells expressing different prostaglandin EP receptors. 2006 Apr 18 3
85 16357326 Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. 2006 Apr 15 2
86 16405508 Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB. 2006 Feb 1
87 16483565 The protease-activated receptor2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: a potential bronchoprotective unit in the respiratory tract? 2006 Mar 8 1
88 16512814 Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors. 2006 Apr 1
89 16784723 Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. 2006 Aug 14 2
90 16982695 Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling. 2006 Nov 4
91 17021176 Bidirectional trafficking of prostaglandin E2 receptors involved in long-term potentiation in visual cortex. 2006 Oct 4 1
92 15722440 Identification and localization of prostaglandin E2 receptors in upper and lower segment human myometrium during pregnancy. 2005 Apr 1
93 15888106 Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells. 2005 May 2
94 15948687 Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha. 2005 Jun 2
95 16081678 Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes. 2005 Nov 2
96 16188227 Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype. 2005 Dec 9 2
97 16262658 Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. 2005 Nov 1
98 29539150 Cyclooxygenase-2-Dependent Prostaglandin (PG) E2 Downregulates Matrix Metalloproteinase-3 Production via EP2 /EP4 Subtypes of PGE2 Receptors in Human Periodontal Ligament Cells Stimulated With Interleukin-1α. 2005 Jun 2
99 14715958 Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. 2004 Jan 7 1
100 14751245 Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth. 2004 Feb 20 1